Istituto Clinico Humanitas
Rozzano, Milano, 20089, Italy
NCT Number: NCT00965627
This is a retrospective analysis of biological characteristics of thymoma and thymic carcinoma patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rozzano, Milano, 20089, Italy
The aim of the present study is to investigated the genetic alterations in tumor samples of a series of all WHO-defined subtypes of thymoma patients using high resolution microarray- comparative genomic hybridization (CGH) followed by hierarchical cluster analyses of the data to identify specific patterns of genetic aberrations and genes associated with each subtype. Moreover, tumor samples will be also investigated for some specific potential therapy targets by immunoistichemistry, mutation analysis, and fluorescence in situ hybridization (FISH) analysis. All these biological data will be correlated with clinical patients characteristics and survival data.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one year
Time frame: one year
Istituto Clinico Humanitas
Other
Biological Analysis of a Series of Thymoma and Thymic Carcinoma: Genetic Aberrations and Potential Therapy Targets.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07649187
Activities of Daily Living, Autoimmune Diseases
Taipei, Taiwan
View Trial DetailsNCT04375267
Adenoma, Clinical Trial, Phase I
Gothenburg, Sweden
View Trial DetailsNCT05255965
Hemic and Lymphatic Diseases, Lymphatic Diseases
Shanghai, China
View Trial DetailsNCT01621568
Hemic and Lymphatic Diseases, Lymphatic Diseases
Bethesda, Maryland, United States
View Trial Details